Want to see CH:AEVS full AI Analyst Report?
AEVS Stock Chart & Stats
CHF13.55
-CHF0.15(-1.08%)
At close: 4:00 PM EST
CHF13.55
-CHF0.15(-1.08%)
Day’s Range― - ―
52-Week RangeCHF11.50 - CHF16.00
Previous CloseN/A
Volume1.36K
Average Volume (3M)73.49K
Market Cap
CHF1.35B
Enterprise ValueCHF2.04K
Total Cash (Recent Filing)CHF63.09M
Total Debt (Recent Filing)CHF1.00B
Price to Earnings (P/E)―
Beta-0.27
Next Earnings
Apr 07, 2027EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend Yield4.01%
Share Statistics
EPS (TTM)-0.23
Shares Outstanding85,151,470
10 Day Avg. Volume15,784
30 Day Avg. Volume73,487
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)2.21
Price to Sales (P/S)0.99
P/FCF Ratio230.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.12
Revenue Forecast (FY)CHF1.12B
Bulls Say, Bears Say
Bulls Say
Strong Revenue And Operating Cash Flow GrowthSustained revenue expansion alongside consistently positive, improving operating cash flow indicates growing activity across the healthcare portfolio. This supports reinvestment and provides an operating stabilizer, although stronger cash conversion is still needed to translate growth into durable returns.
Healthcare Margin ExpansionMargin improvement at the core healthcare platform suggests operating leverage from ramping hospitals and disciplined material and personnel costs. Continued progress could make earnings more resilient and support the company’s stated path toward healthcare margins above 20%.
Scalable Integrated-care PlatformThe integrated-care model combines demonstrated cost improvement with geographic expansion and membership growth ambitions. Reaching scale can improve economics over time, while the existing three-region footprint and planned Bern launch provide a platform for broader healthcare integration.
Bears Say
High Leverage Limits Financial FlexibilityDebt materially exceeds the equity base, increasing financial risk and reducing flexibility to absorb operational setbacks or fund new investments. Although management reported deleveraging and lower interest expense, the overall balance sheet remains highly leveraged.
Growth Has Not Produced Durable Net EarningsThe company has expanded revenue without consistently converting that growth into net profit, while volatile free cash flow points to continuing capital needs. Persistent losses can constrain deleveraging and make future performance more dependent on operational improvement.
Uneven Profitability Across Portfolio AssetsProfitability weakness in turnaround hospitals and Réseau de l’Arc shows that portfolio performance remains uneven despite stronger group margins. Recovery depends on operational changes and efficiency measures, leaving execution risk in these assets over the coming quarters.
AEVIS VICTORIA SA News
AEVS FAQ
What was AEVIS VICTORIA SA’s price range in the past 12 months?
AEVIS VICTORIA SA lowest stock price was CHF11.50 and its highest was CHF16.00 in the past 12 months.
What is AEVIS VICTORIA SA’s market cap?
AEVIS VICTORIA SA’s market cap is CHF1.35B.
When is AEVIS VICTORIA SA’s upcoming earnings report date?
AEVIS VICTORIA SA’s upcoming earnings report date is Apr 07, 2027 which is in 193 days.
How were AEVIS VICTORIA SA’s earnings last quarter?
AEVIS VICTORIA SA released its earnings results on Sep 17, 2026. The company reported CHF0.064 earnings per share for the quarter, missing the consensus estimate of CHF0.18 by -CHF0.116.
Is AEVIS VICTORIA SA overvalued?
According to Wall Street analysts AEVIS VICTORIA SA’s price is currently Overvalued.
Does AEVIS VICTORIA SA pay dividends?
AEVIS VICTORIA SA pays a Notavailable dividend of CHF0.3 which represents an annual dividend yield of 4.01%. See more information on AEVIS VICTORIA SA dividends here
What is AEVIS VICTORIA SA’s EPS estimate?
AEVIS VICTORIA SA’s EPS estimate is -0.01.
How many shares outstanding does AEVIS VICTORIA SA have?
AEVIS VICTORIA SA has 85,151,470 shares outstanding.
What happened to AEVIS VICTORIA SA’s price movement after its last earnings report?
AEVIS VICTORIA SA reported an EPS of CHF0.064 in its last earnings report, missing expectations of CHF0.18. Following the earnings report the stock price went up 8.029%.
Which hedge fund is a major shareholder of AEVIS VICTORIA SA?
Currently, no hedge funds are holding shares in CH:AEVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AEVIS VICTORIA SA
Aevis Victoria SA is a Swiss holding company with diversified interests spanning the healthcare, hospitality, lifestyle, and infrastructure sectors. Its operational structure is divided into key segments: Hospitals, Hospitality, Telemedicine, and Real Estate. The group manages an extensive portfolio, which includes 22 hospitals providing 1,496 beds, and oversees 941 rooms within its real estate holdings, representing a total rentable area of 188,109 square meters. Beyond its core hospital services, Aevis Victoria offers telemedicine, ambulance transport, and day clinic facilities. Its broad range of business ventures further encompasses patient hotels, "better aging" programs, radiology institutes, pharmacies, ophthalmology clinics, property management, stem cell applications, cosmetic services, and publishing, alongside organizing various seminars. The company's corporate headquarters are situated in Fribourg, Switzerland, and it operates as a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A.
Technical Analysis
DocMorris
―
Basilea Pharmaceutica
―
Medacta Group SA
―
Galenica AG
―
Medartis Holding AG
―